Bottema C D, Bottema M J, Ketterling R P, Yoon H S, Janco R L, Phillips J A, Sommer S S
Department of Biochemistry and Molecular Biology, Mayo Clinic/Foundation, Rochester, MN 55905.
Am J Hum Genet. 1991 Oct;49(4):839-50.
The factor IX gene has a G + C content of approximately 40% in all mammalian species examined. In human factor IX, C----T and G----A transitions at the dinucleotide CpG are elevated at least 24-fold relative to other transitions. Can the G + C content be explained solely by this hot spot of mutation? Using our mathematical model, we show that the elevation of mutation at CpG cannot alone lower the G + C content below 45%. To search for other hot spots of mutation that might contribute to the reduction of G + C content, we assessed the relative rates of base substitution in our sample of 160 families with hemophilia B. Seventeen independent single-base substitutions are reported herein for a total of 96 independent point mutations in our sample. The following conclusions emerge from the analysis of our data and, where appropriate, the data of others: (1) Transversions at CpG are elevated an estimated 7.7-fold relative to other transversions. (2) The mutation rates at non-CpG dinucleotides are remarkably uniform; none of the observed rates are either more than twofold above the median for transitions or more than threefold above the median for transversions. (3) The pattern of recent mutation is compatible with the pattern during mammalian evolution that has maintained the G + C content of the factor IX gene at approximately 40%.
在所有已检测的哺乳动物物种中,凝血因子IX基因的G + C含量约为40%。在人类凝血因子IX中,二核苷酸CpG处的C→T和G→A转换相对于其他转换至少升高了24倍。G + C含量能否仅由这个突变热点来解释呢?利用我们的数学模型,我们表明CpG处突变的升高本身并不能使G + C含量降低到45%以下。为了寻找可能导致G + C含量降低的其他突变热点,我们评估了160个乙型血友病家庭样本中的碱基替换相对速率。本文报告了17个独立的单碱基替换,我们样本中共有96个独立的点突变。根据我们的数据以及在适当情况下参考其他数据的分析得出了以下结论:(1)CpG处的颠换相对于其他颠换估计升高了7.7倍。(2)非CpG二核苷酸处的突变率非常均匀;观察到的速率中没有一个比转换的中位数高出两倍以上,也没有一个比颠换的中位数高出三倍以上。(3)近期的突变模式与哺乳动物进化过程中的模式相符,后者使凝血因子IX基因的G + C含量维持在约40%。